Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Research: Proscia AI Predicts Diagnostic Agreement for Melanoma

By Author Proscia | November 2, 2022

The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance.

Our website uses cookies. By using this site, you agree to its use of cookies.